Linked Data API

Show Search Form

Search Results

1050512
registered interest false more like this
date less than 2019-01-29more like thismore than 2019-01-29
answering body
Department of Health and Social Care more like this
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Drugs remove filter
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure that GP surgeries are supplied with adequate guidance for patients on their medication in the event that the UK leaves the EU without a deal. more like this
tabling member constituency Birmingham, Northfield more like this
tabling member printed
Richard Burden more like this
uin 213939 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2019-02-06more like thismore than 2019-02-06
answer text <p>Guidance issued to all National Health Service trusts, pharmacies and general practices by the Department and NHS England has informed them of our plans for ensuring continuity of supply of medicines and advised them that they can expect to be able to continue accessing medicines through their existing supply routes in the event of a ‘no deal’ European Union exit. General practitioners (GPs) and providers should continue to prescribe medicines and other medical products as normal.</p><p> </p><p>On 23 August 2018, my Rt. hon. Friend the Secretary of State for Health and Social Care sent a letter to NHS England outlining preparations for the EU Exit, including in relation to General Practice. On 21 December 2018, the EU Exit Operational Guidance for the Health and Social Care system, including GPs, was issued. On 18 January 2019, a joint letter from the Department and NHS England from chief pharmacist, Keith Ridge, was sent to GPs, pharmacists and senior leaders within the NHS.</p><p> </p>
answering member constituency Wimbledon more like this
answering member printed Stephen Hammond more like this
question first answered
less than 2019-02-06T17:09:00.473Zmore like thismore than 2019-02-06T17:09:00.473Z
answering member
1585
label Biography information for Stephen Hammond more like this
tabling member
301
label Biography information for Richard Burden more like this
1041248
registered interest false more like this
date less than 2019-01-14more like thismore than 2019-01-14
answering body
Department of Health and Social Care more like this
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Drugs remove filter
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, whether his Department's plans to ensure the supply of medicines in the event of the UK leaving the EU without a deal (a) have been or (b) will be subjected to an independent evaluation. more like this
tabling member constituency Ilford North more like this
tabling member printed
Wes Streeting more like this
uin 208297 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2019-01-17more like thismore than 2019-01-17
answer text <p>The Department’s plans to ensure the supply of medicines in the event of the United Kingdom leaving the European Union without a deal have been subject to scrutiny by a number of Parliamentary Committees, including the Public Accounts Committee, the Health and Social Care Committee, the EU Exit Committee and the House of Lords EU Home Affairs Sub-Committee. The Department is also working closely with suppliers, their supply chains, health services and devolved administrations to maintain the continuity of medicines supply in a ‘no deal’ EU exit scenario.</p><p> </p><p>We are unable to publish the list of medicines requested. To reassure participating companies, we have committed to treating all information received confidentially, securely and to using it only for the purposes of the Department’s contingency programme. That means not introducing information about a specific company, medicine or supply route into the public domain.</p><p> </p><p>On 23 August 2018, the Department wrote to all pharmaceutical companies that supply prescription-only and pharmacy medicines to the UK that come from, or via, the EU or European Economic Area (EEA), asking them to ensure a minimum of six weeks’ additional supply in the UK, over and above existing business-as-usual buffer stocks, by 29 March 2019. We recognise, however, that certain medicines with short shelf lives, including medical radioisotopes, cannot be reasonably stockpiled. Where these medicines are imported from the EU or EEA, we have asked that suppliers ensure in advance plans to air freight these medicines from the EU in the event of a ‘no deal’ exit.</p><p> </p><p>Additionally, on 7 December 2018, the Department wrote to pharmaceutical companies that supply licensed medicines to the UK from or via the EU/EEA and/or manufacture medicines in the UK, informing them of the updated reasonable worst-case scenario border disruption planning assumptions and asking them about their current transportation routes and their ability to re-route their supply chains if they currently rely on Dover and/or Folkestone.</p><p> </p><p>We have received very good engagement from industry who share our aims of ensuring continuity of medicines supply for patients is maintained and that suppliers are able to cope with any potential delays at the border that may arise in the short term in the event of a ‘no deal’ exit.</p>
answering member constituency Wimbledon more like this
answering member printed Stephen Hammond more like this
grouped question UIN 208298 more like this
question first answered
less than 2019-01-17T16:27:06.083Zmore like thismore than 2019-01-17T16:27:06.083Z
answering member
1585
label Biography information for Stephen Hammond more like this
tabling member
4504
label Biography information for Wes Streeting more like this
1041249
registered interest false more like this
date less than 2019-01-14more like thismore than 2019-01-14
answering body
Department of Health and Social Care more like this
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Drugs remove filter
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, if he will publish (a) a list of medicines for which there is a supply risk in the event of the UK leaving the EU without a deal and (b) a plan to mitigate those supply risks. more like this
tabling member constituency Ilford North more like this
tabling member printed
Wes Streeting more like this
uin 208298 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2019-01-17more like thismore than 2019-01-17
answer text <p>The Department’s plans to ensure the supply of medicines in the event of the United Kingdom leaving the European Union without a deal have been subject to scrutiny by a number of Parliamentary Committees, including the Public Accounts Committee, the Health and Social Care Committee, the EU Exit Committee and the House of Lords EU Home Affairs Sub-Committee. The Department is also working closely with suppliers, their supply chains, health services and devolved administrations to maintain the continuity of medicines supply in a ‘no deal’ EU exit scenario.</p><p> </p><p>We are unable to publish the list of medicines requested. To reassure participating companies, we have committed to treating all information received confidentially, securely and to using it only for the purposes of the Department’s contingency programme. That means not introducing information about a specific company, medicine or supply route into the public domain.</p><p> </p><p>On 23 August 2018, the Department wrote to all pharmaceutical companies that supply prescription-only and pharmacy medicines to the UK that come from, or via, the EU or European Economic Area (EEA), asking them to ensure a minimum of six weeks’ additional supply in the UK, over and above existing business-as-usual buffer stocks, by 29 March 2019. We recognise, however, that certain medicines with short shelf lives, including medical radioisotopes, cannot be reasonably stockpiled. Where these medicines are imported from the EU or EEA, we have asked that suppliers ensure in advance plans to air freight these medicines from the EU in the event of a ‘no deal’ exit.</p><p> </p><p>Additionally, on 7 December 2018, the Department wrote to pharmaceutical companies that supply licensed medicines to the UK from or via the EU/EEA and/or manufacture medicines in the UK, informing them of the updated reasonable worst-case scenario border disruption planning assumptions and asking them about their current transportation routes and their ability to re-route their supply chains if they currently rely on Dover and/or Folkestone.</p><p> </p><p>We have received very good engagement from industry who share our aims of ensuring continuity of medicines supply for patients is maintained and that suppliers are able to cope with any potential delays at the border that may arise in the short term in the event of a ‘no deal’ exit.</p>
answering member constituency Wimbledon more like this
answering member printed Stephen Hammond more like this
grouped question UIN 208297 more like this
question first answered
less than 2019-01-17T16:27:06.143Zmore like thismore than 2019-01-17T16:27:06.143Z
answering member
1585
label Biography information for Stephen Hammond more like this
tabling member
4504
label Biography information for Wes Streeting more like this
1037913
registered interest false more like this
date less than 2019-01-08more like thismore than 2019-01-08
answering body
Department of Health and Social Care more like this
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Drugs remove filter
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, pursuant to Answer of 7 January 2019 to Question 203449 on Drugs, whether all the additional medicine warehousing capacity referred to in that Answer has been built. more like this
tabling member constituency Ellesmere Port and Neston more like this
tabling member printed
Justin Madders more like this
uin 206391 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2019-01-16more like thismore than 2019-01-16
answer text <p>Contract agreements for storage have recently been signed or will be signed imminently. We have agreed funding on the condition that the additional medicine warehousing capacity is in place in time to accommodate stockpiled medicines by the beginning of February 2019.</p><p> </p><p>Those warehouses are all in existence and have planning permission. It is for those contractors to determine the best means of ensuring that the warehouses are adequately staffed in line with their normal business practices.</p> more like this
answering member constituency Wimbledon more like this
answering member printed Stephen Hammond more like this
grouped question UIN
206392 more like this
206393 more like this
question first answered
less than 2019-01-16T12:41:22.31Zmore like thismore than 2019-01-16T12:41:22.31Z
answering member
1585
label Biography information for Stephen Hammond more like this
tabling member
4418
label Biography information for Justin Madders more like this
1037914
registered interest false more like this
date less than 2019-01-08more like thismore than 2019-01-08
answering body
Department of Health and Social Care more like this
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Drugs remove filter
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 7 January 2019 to Question 203449 on Drugs, whether all the additional medicine warehousing capacity referred to in that Answer has received planning permission from the relevant local authority. more like this
tabling member constituency Ellesmere Port and Neston more like this
tabling member printed
Justin Madders more like this
uin 206392 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2019-01-16more like thismore than 2019-01-16
answer text <p>Contract agreements for storage have recently been signed or will be signed imminently. We have agreed funding on the condition that the additional medicine warehousing capacity is in place in time to accommodate stockpiled medicines by the beginning of February 2019.</p><p> </p><p>Those warehouses are all in existence and have planning permission. It is for those contractors to determine the best means of ensuring that the warehouses are adequately staffed in line with their normal business practices.</p> more like this
answering member constituency Wimbledon more like this
answering member printed Stephen Hammond more like this
grouped question UIN
206391 more like this
206393 more like this
question first answered
less than 2019-01-16T12:41:22.357Zmore like thismore than 2019-01-16T12:41:22.357Z
answering member
1585
label Biography information for Stephen Hammond more like this
tabling member
4418
label Biography information for Justin Madders more like this
1037915
registered interest false more like this
date less than 2019-01-08more like thismore than 2019-01-08
answering body
Department of Health and Social Care more like this
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Drugs remove filter
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, pursuant to Answer of 7 January 2019 to Question 203449 on Drugs, what recruitment has taken place to staff the additional medicine warehousing capacity referred to in that Answer. more like this
tabling member constituency Ellesmere Port and Neston more like this
tabling member printed
Justin Madders more like this
uin 206393 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2019-01-16more like thismore than 2019-01-16
answer text <p>Contract agreements for storage have recently been signed or will be signed imminently. We have agreed funding on the condition that the additional medicine warehousing capacity is in place in time to accommodate stockpiled medicines by the beginning of February 2019.</p><p> </p><p>Those warehouses are all in existence and have planning permission. It is for those contractors to determine the best means of ensuring that the warehouses are adequately staffed in line with their normal business practices.</p> more like this
answering member constituency Wimbledon more like this
answering member printed Stephen Hammond more like this
grouped question UIN
206391 more like this
206392 more like this
question first answered
less than 2019-01-16T12:41:22.403Zmore like thismore than 2019-01-16T12:41:22.403Z
answering member
1585
label Biography information for Stephen Hammond more like this
tabling member
4418
label Biography information for Justin Madders more like this
1027714
registered interest false more like this
date less than 2018-12-18more like thismore than 2018-12-18
answering body
Department of Health and Social Care more like this
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Drugs remove filter
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, pursuant to the Answer on 11 September to Question number 169109 on Social Care: Drugs, (a) when the 2019-20 planning process was completed and (b) what the level of funding is for the 2019-20 prioritisation process. more like this
tabling member constituency Alyn and Deeside more like this
tabling member printed
Mark Tami more like this
uin 203288 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2018-12-20more like thismore than 2018-12-20
answer text <p>The independently chaired Clinical Priorities Advisory Group met in November 2018 to make prioritisation recommendations for investments in specialised service for the 2019/20 financial year. Final investment decisions will be announced shortly. A second prioritisation round for investment in 2019/20 will be held next year.</p><p> </p><p>The baseline budget for prioritisation in 2019/20 has been set at £25.7 million reflecting a 2.7% increase on the 2018/19 budget. The availability of any additional funding to support prioritisation will be kept under review between now and May/June 2019 when the second round of investment decisions will be taken for the 2019/20 financial year.</p> more like this
answering member constituency Winchester more like this
answering member printed Steve Brine more like this
question first answered
less than 2018-12-20T15:58:15.86Zmore like thismore than 2018-12-20T15:58:15.86Z
answering member
4067
label Biography information for Steve Brine more like this
tabling member
1383
label Biography information for Mark Tami more like this
1027757
registered interest false more like this
date less than 2018-12-18more like thismore than 2018-12-18
answering body
Department of Health and Social Care more like this
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Drugs remove filter
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, how many days’ worth and what value of drugs which cannot be refrigerated his Department (a) has already stockpiled and (b) is planning to stockpile in preparation the UK leaving the EU without a deal. more like this
tabling member constituency Liverpool, Wavertree more like this
tabling member printed
Luciana Berger more like this
uin 203446 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2019-01-07more like thismore than 2019-01-07
answer text <p>On 23 August 2018, the Department wrote to all pharmaceutical companies that supply prescription only medicines and pharmacy medicines to the UK that come from, or via, the European Union or European Economic Area asking them to ensure a minimum of 42 days additional supply in the United Kingdom, over and above existing business-as-usual buffer stocks, by 29 March 2019.</p><p> </p><p>The Department does not hold information about the value of the medicines that will be stockpiled in either refrigerated or non-refrigerated storage. The medicines will remain the property of the suppliers who would hold that information. Since then we have received very good engagement from industry who share our aims of ensuring continuity of medicines supply for patients is maintained and able to cope with any potential delays at the border that may arise in the short term in the event of a ‘no deal’ EU exit.</p><p> </p><p>In the light of this engagement the Department is currently considering how best it may support industry taking part in the contingency planning.</p><p> </p><p>In October, a tender process to secure the provision of additional warehouse space for stockpiled medicines covering ambient, cold chain and controlled drug storage was undertaken. Contract agreements for the procurement of storage, including refrigerated storage have recently been signed. The sum total cost of additional warehouse is expected to cost the Government in the low tens of millions of pounds.</p><p> </p><p>We have agreed funding on the condition that the additional medicine warehousing capacity is in place in time to accommodate stockpiled medicines by the beginning of February 2019. The storage space needs to be available for 12 months to allow for stock build and stock wind down.</p><p> </p><p>To reassure participating companies, we have committed to treating all information received confidentially, securely and to using it only for the purposes of the Department’s programme. That means not introducing information about a company or a specific medicine into the public domain.</p>
answering member constituency Wimbledon more like this
answering member printed Stephen Hammond more like this
grouped question UIN
203447 more like this
203448 more like this
203449 more like this
question first answered
less than 2019-01-07T16:18:47.06Zmore like thismore than 2019-01-07T16:18:47.06Z
answering member
1585
label Biography information for Stephen Hammond more like this
tabling member
4036
label Biography information for Luciana Berger more like this
1027758
registered interest false more like this
date less than 2018-12-18more like thismore than 2018-12-18
answering body
Department of Health and Social Care more like this
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Drugs remove filter
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, what estimate his Department has made of the cost to the public purse of stockpiling medicines that cannot be refrigerated for the event of the UK leaving the EU without a deal (a) to date, (b) until 29 March 2019 and (c) after 29 March 2019. more like this
tabling member constituency Liverpool, Wavertree more like this
tabling member printed
Luciana Berger more like this
uin 203447 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2019-01-07more like thismore than 2019-01-07
answer text <p>On 23 August 2018, the Department wrote to all pharmaceutical companies that supply prescription only medicines and pharmacy medicines to the UK that come from, or via, the European Union or European Economic Area asking them to ensure a minimum of 42 days additional supply in the United Kingdom, over and above existing business-as-usual buffer stocks, by 29 March 2019.</p><p> </p><p>The Department does not hold information about the value of the medicines that will be stockpiled in either refrigerated or non-refrigerated storage. The medicines will remain the property of the suppliers who would hold that information. Since then we have received very good engagement from industry who share our aims of ensuring continuity of medicines supply for patients is maintained and able to cope with any potential delays at the border that may arise in the short term in the event of a ‘no deal’ EU exit.</p><p> </p><p>In the light of this engagement the Department is currently considering how best it may support industry taking part in the contingency planning.</p><p> </p><p>In October, a tender process to secure the provision of additional warehouse space for stockpiled medicines covering ambient, cold chain and controlled drug storage was undertaken. Contract agreements for the procurement of storage, including refrigerated storage have recently been signed. The sum total cost of additional warehouse is expected to cost the Government in the low tens of millions of pounds.</p><p> </p><p>We have agreed funding on the condition that the additional medicine warehousing capacity is in place in time to accommodate stockpiled medicines by the beginning of February 2019. The storage space needs to be available for 12 months to allow for stock build and stock wind down.</p><p> </p><p>To reassure participating companies, we have committed to treating all information received confidentially, securely and to using it only for the purposes of the Department’s programme. That means not introducing information about a company or a specific medicine into the public domain.</p>
answering member constituency Wimbledon more like this
answering member printed Stephen Hammond more like this
grouped question UIN
203446 more like this
203448 more like this
203449 more like this
question first answered
less than 2019-01-07T16:18:47.123Zmore like thismore than 2019-01-07T16:18:47.123Z
answering member
1585
label Biography information for Stephen Hammond more like this
tabling member
4036
label Biography information for Luciana Berger more like this
1027760
registered interest false more like this
date less than 2018-12-18more like thismore than 2018-12-18
answering body
Department of Health and Social Care more like this
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Drugs remove filter
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, if he will list the drugs his Department is stockpiling for the UK leaving the EU; and how much his Department has spent to date on stockpiling those drugs. more like this
tabling member constituency Liverpool, Wavertree more like this
tabling member printed
Luciana Berger more like this
uin 203449 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2019-01-07more like thismore than 2019-01-07
answer text <p>On 23 August 2018, the Department wrote to all pharmaceutical companies that supply prescription only medicines and pharmacy medicines to the UK that come from, or via, the European Union or European Economic Area asking them to ensure a minimum of 42 days additional supply in the United Kingdom, over and above existing business-as-usual buffer stocks, by 29 March 2019.</p><p> </p><p>The Department does not hold information about the value of the medicines that will be stockpiled in either refrigerated or non-refrigerated storage. The medicines will remain the property of the suppliers who would hold that information. Since then we have received very good engagement from industry who share our aims of ensuring continuity of medicines supply for patients is maintained and able to cope with any potential delays at the border that may arise in the short term in the event of a ‘no deal’ EU exit.</p><p> </p><p>In the light of this engagement the Department is currently considering how best it may support industry taking part in the contingency planning.</p><p> </p><p>In October, a tender process to secure the provision of additional warehouse space for stockpiled medicines covering ambient, cold chain and controlled drug storage was undertaken. Contract agreements for the procurement of storage, including refrigerated storage have recently been signed. The sum total cost of additional warehouse is expected to cost the Government in the low tens of millions of pounds.</p><p> </p><p>We have agreed funding on the condition that the additional medicine warehousing capacity is in place in time to accommodate stockpiled medicines by the beginning of February 2019. The storage space needs to be available for 12 months to allow for stock build and stock wind down.</p><p> </p><p>To reassure participating companies, we have committed to treating all information received confidentially, securely and to using it only for the purposes of the Department’s programme. That means not introducing information about a company or a specific medicine into the public domain.</p>
answering member constituency Wimbledon more like this
answering member printed Stephen Hammond more like this
grouped question UIN
203446 more like this
203447 more like this
203448 more like this
question first answered
less than 2019-01-07T16:18:47.217Zmore like thismore than 2019-01-07T16:18:47.217Z
answering member
1585
label Biography information for Stephen Hammond more like this
tabling member
4036
label Biography information for Luciana Berger more like this